Template:Clinical dosage ranges of oral and injectable androgens and anabolic steroids

From blackwiki
Jump to navigation Jump to search

Clinical dosage ranges of oral and injectable androgens and anabolic steroids

Collapse
Route Medication Major brand names Dosage range
Oral Template:No selflink Danocrine 100–800 mg/day
Template:No selflink Maxibolin, Orabolin 2–8 mg/day
Template:No selflink Halotestin, Ora-Testryl, Ultandren 2–40 mg/day
Template:No selflink Proviron 25–150 mg/day
Template:No selflink Dianabol 2.5–15 mg/day
Template:No selflink Primobolan 10–150 mg/day
Template:No selflink Android, Metandren, Testred 1.5–200 mg/day
Template:No selflink Nilevar, Pronabol 20–30 mg/day
Template:No selflink Anavar, Oxandrin 2.5–20 mg/day
Template:No selflink Anadrol, Anapolon 1–5 mg/kg/day (50–150 mg/day)
Template:No selflink Winstrol 2–6 mg/day
Template:No selflinka 400–800 mg/day (in divided doses)
Template:No selflink Andriol, Jatenzo 40–80 mg/2–4x day (with food)
Injection Template:No selflink Drolban, Masteril, Masteron 100 mg 3x/week
Template:No selflink Primobolan Depot 25–100 mg/week
Template:No selflink Deca-Durabolin 12.5–200 mg/week (total)
Template:No selflink Durabolin 6.25–200 mg/week (total)
Template:No selflink Winstrol Depot 50 mg 1x/2–3 weeks
Template:No selflink Andronaq, Sterotate, Virosterone 25–100 mg 2–3x/week
Template:No selflink Depo-Testosterone 50–400 mg 1x/1–4 weeks
Template:No selflink Delatestryl 50–400 mg 1x/1–4 weeks
Template:No selflink Testoviron 25–50 mg 2–3x/week
Template:No selflink Aveed, Nebido 750–1,000 mg 1x/10–14 weeks
Template:No selflink Hexabolan, Parabolan 75 mg/1.5 weeks
Note: Dosage ranges are for varying indications and are not necessarily equivalent. Footnotes: a = Studied for male hypogonadism but never marketed. For comparison purposes. Sources: General: [1][2][3][4][5][6][7][8] Additional: [9][10]
Template documentation

See also

References

  1. "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 1 December 2019.
  2. Richard Joseph Hamilton; Nancy Anastasi Duffy; Daniel Stone (2014). Tarascon Pharmacopoeia. Jones & Bartlett Publishers. pp. 174–. ISBN 978-1-284-05671-6.
  3. Susan M. Ford; Sally S. Roach (2010). Roach's Introductory Clinical Pharmacology. Lippincott Williams & Wilkins. pp. 499–. ISBN 978-1-60547-633-9.
  4. Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 1358–. ISBN 978-1-60913-345-0.
  5. Brent C Mangus; Michael G Miller (11 January 2005). Pharmacology Application in Athletic Training. F.A. Davis. pp. 151–. ISBN 978-0-8036-2027-8.
  6. John A. Thomas (6 December 2012). Drugs, Athletes, and Physical Performance. Springer Science & Business Media. pp. 20–. ISBN 978-1-4684-5499-4.
  7. William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. ISBN 978-0-9828280-1-4.
  8. Burkett, Lee N.; Falduto, Michael T. (1984). "Steroid Use by Athletes in a Metropolitan Area". The Physician and Sportsmedicine. 12 (8): 69–74. doi:10.1080/00913847.1984.11701923. ISSN 0091-3847.
  9. J. Bain; Wolf-Bernhard Schill; L. Schwarzstein (6 December 2012). Treatment of Male Infertility. Springer Science & Business Media. pp. 176–177. ISBN 978-3-642-68223-0.
  10. Snyder, P J (1984). "Clinical Use of Androgens". Annual Review of Medicine. 35 (1): 207–217. doi:10.1146/annurev.me.35.020184.001231. ISSN 0066-4219.